Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The endocannabinoid system: a putative role in neurodegenerative diseases.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients.
How Patients With Multiple Sclerosis Perceive Cognitive Slowing.
White matter disease: Hyaluronidase PH-20 digestion products inhibit remyelination in demyelinating lesions.
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica.
Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients.
Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.
Oligodendrocyte progenitor cells: the ever mitotic cells of the CNS.
Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort.
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.
A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis.
[Present and future of the transcranial magnetic stimulation].
[Registries for neurological drugs landscape].
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.
Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact.
Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of anexperimental autoimmune encephalomyelitis model.
Pages
« first
‹ previous
…
356
357
358
359
360
361
362
363
364
…
next ›
last »